We demonstrated that MYB promoters have cell-type specific activity and MYB TSS2 activation occurs in ACC tumors, suggesting that the underlying cause of TSS2 activation could be specific to ACC tumors. This evidence concerns the gene MYB and adrenal cortex carcinoma.